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Abstract 
Ligand field molecular mechanics (LFMM) and semi-empirical Parametric Model 7 (PM7) 
methods are applied to a series of six PtII-Ligand systems binding to the N-terminal domain of 
the amyloid-β (Aβ) peptide. Molecular dynamics using a combined LFMM/Assisted Model 
Building with Energy Refinement (AMBER) approach is used to explore the conformational 
freedom of the peptide fragment, and identifies favourable platinum binding modes and peptide 
conformations for each ligand investigated. Platinum coordination is found to depend on the 
nature of the ligand, providing evidence that binding mode may be controlled by suitable ligand 
design. Boltzmann populations at 310K indicate that each Pt-Aβ complex has a small number 
of thermodynamically accessible states. Ramachandran maps are constructed for the sampled 
Pt-Aβ conformations and secondary structural analysis of the obtained complex structures is 
performed and contrasted with the free peptide; coordination of these platinum complexes 
disrupts existing secondary structure in the Aβ peptide and promotes formation of ligand-
specific turn-type secondary structure. 
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Introduction 
Alzheimer’s disease (AD) is a neurodegenerative condition associated with progressive 
cognitive decline in patients and is the most common cause of late-life dementia1. The causes 
and development of AD are poorly understood, as the disease involves a variety of 
physiological processes2. The two main hallmarks of AD are the presence of extracellular 
plaques and intracellular neurofibrillary tangles3. Amyloid-β (Aβ) peptide was first identified 
as a key component of these plaques in 19854, and has become the focus of much research 
interest in possible AD-therapeutics. The amyloid-cascade hypothesis3,5,6,7,8,9 suggests that Aβ 
monomers aggregate to form these plaques, which are widely believed to be one of the key 
drivers of the condition. As a result, the early stages of the Aβ aggregation process have become 
a target for the development of AD-therapeutics2. 
Aβ monomers are usually 40 or 42 residues long and contain a hydrophilic N-terminal domain 
with high-affinity metal binding sites, particularly the His-rich region at residues 1-16. This 
region of Aβ has been widely reported as being responsible for physiological coordination of 
transition metals such as copper. However, there appears to be some breakdown in the metal 
transport mechanisms in the AD process, as analysis of amyloid deposits has shown increased 
concentrations of these transition metal ions,10,11 suggesting that these metals are important in 
the development of Aβ plaques. To date, metal binding sites have not been clearly defined, 
with many authors demonstrating different metal coordination, although the N-terminal 
histidine residues (His6, His13, His14) appear frequently.12,13,14,15 One possible route to AD-
therapeutics involves disrupting the coordination of the physiological metal ions using 
compounds that selectively occupy the transition metal binding sites, thereby hindering the Aβ 
aggregation process. To this end, Barnham et al.16,17 showed that PtII(phenanthroline) 
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complexes are able to inhibit Aβ aggregation and limit its neurotoxicity in vitro. The presence 
of aromatic ligands appears to be important for activity, as these ligands show some affinity 
for Aβ18 and are able to form stabilising π-π interactions with residues Phe, Tyr and His18 while 
the archetypal PtII
 
drug cisplatin is inactive towards Aβ aggregation. In addition, these PtII 
complexes are not toxic at the concentrations required to inhibit the aggregation of Aβ16. 
However, characterization of these PtII(ligand)-Aβ complexes is difficult, with authors 
suggesting a variety of different metal binding modes16,19,20. Experimental evidence indicates 
that a series of platinated adducts are formed when PtII(phenanthroline) complexes bind to Aβ, 
though the N-terminal His6 and His14 residues are the most common PtII binding sites16,19,20,21. 
Computational approaches may provide clear insight into this problem, without the need for 
complex synthesis. Of particular note is work by Streltsov et al., which combined Extended X-
ray Absorption Fine Structure (EXAFS) and Density Functional Theory (DFT) data for a series 
of model PtII complexes to provide predictions of metal-aβ binding modes22.  
However, computational modelling of these metal-peptide systems is challenging; quantum 
mechanical (QM) methods are not typically applied to the study of large, flexible peptide 
systems such as Aβ for reasons of computational cost, while classical modelling techniques 
(i.e. molecular mechanics (MM)) do not model the influence of metal d-shell electrons on the 
structure and properties of transition metal coordination complexes23. Alternatively, ligand 
field molecular mechanics (LFMM)24,25,26 appears well-suited to the study of these transition 
metal – biomolecule interactions, by introducing a Ligand Field Stabilisation Energy (LFSE) 
term into the construction of the forcefield in order to handle the d-orbital electron effects. This 
gives δFεε ‘the flexibility and generality of quantum mechanics with the speed of molecular 
mechanics.’23 which has allowed success in the modelling of a range of Jahn-Teller active CuII 
systems27, spin states of Ni and Fe complexes28 as well as some PtII-biomolecule studies29,30,31. 
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The aim of this work is to generate and subsequently analyse conformations of a series of PtII 
species bound to a fragment of Aβ peptide (residues 6-14 – see Figure 1), in order to identify 
favourable platinum-binding modes and peptide conformations. This peptide was chosen for 
study as it contains the N-terminal residues necessary to study transition metal binding, and is 
sufficiently small to allow calibration of findings through use of DFT. This work presents 
findings for six platinum-ligand systems (see Figure 2), which stem from recent literature. The 
modelling approaches outlined here may be extended to study other ligands20, other transition-
metal based therapeutics of current research interest (e.g. ruthenium32 and mixed-metal 
complexes33,34).  
 
Computational Methods 
The peptide sequence His6-Asp-Ser-Gly-Tyr-Glu-Val-His-His14 was built in an extended 
conformation in Molecular Operating Environment (MOE)35, and protonation states at pH of 
7.4 assigned using the Protonate3D module of this package. PtII(ligand) complexes were 
manually constructed and bound to the peptide in eight distinct binding modes from all 
combinations of N / N  of His6 and  His13/His14.  For conformational searching, complexes 
were described using a combination of ligand field molecular mechanics (LFMM) for PtII 23,29,30 
and Assisted Model Building with Energy Refinement (AMBER94)36 parameters for all other 
atoms, as implemented in the d-orbital extension to MOE (DommiMOE)26. Partial charges 
were calculated for model PtII(imidazole)2(ligand) systems using the Merz-Kollman scheme 
from HF/6-31G(d)/SDD electrostatic potential in Gaussian0937, with PtII given a van der Waals 
radius of 2.0 Å. The remaining peptide atoms were assigned AMBER94 charges as calculated 
by MOE. Solvation effects were modelled using the reaction-field model with default 
parameters. 
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Conformational freedom was explored via the LowMode MD (LMMD)38 method in MOE. 
LMMD searches were configured to terminate after 100 successive failures to generate a new 
conformation up to a maximum of 10,000 iterations, with a large energy cut-off (10,000 
kcal/mol) and a Root-Mean-Square Deviation (RMSD) cut-off of 0.25 Å used for removal of 
any duplicate conformations. During the LMMD search, the platinum centre was set at a fixed 
potential to avoid premature termination of the conformational search.31 Semi-empirical 
calculations were performed using the Molecular Orbital PACkage (MOPAC) in its 201239 
version, with the Parametric Model 7 (PM7) method40 and the Conductor-like Screening Model 
(COSMO) model of aqueous solvation41. Overlay plots and images were obtained using 
Chimera imaging software42. Ramachandran maps were plotted using the JMP statistical 
package43. 
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Results and Discussion 
In this work, we generate and analyse conformations of a series of PtII species (see Figure 2) 
bound to a fragment of Aβ peptide, with the aim of identifying favourable metal-binding modes 
and peptide conformations. Using the protocol outlined above, we performed conformational 
searches on each platinum binding mode for all ligand systems (8 for the symmetric ligands 1 
- 4; 16 for asymmetric ligands 5 and 6). This produced a large number of possible conformers 
for each platinum binding mode (Table 1).  
There is significant variation in the number of conformations found between these different 
ligands and coordination modes, which may be partly due to the stochastic nature of the LMMD 
search as well as the effect of different complexes/coordination modes on peptide flexibility. 
In comparison, an identical simulation using the free peptide fragment produced 9962 
conformations, emphasising the fact that coordination of these platinum complexes greatly 
reduces the conformational freedom of Aβ31. 
It is particularly notable that both asymmetric ligands produced significantly greater numbers 
of possible structures than their symmetric counterparts. While some of this difference may be 
attributed to the increased number of conformational searches required for these systems, i.e. 
two different simulations for the two orientations of the ligands, with the ligand 5-membered 
ring cis- or trans- to His6, this does not explain the large numbers of structures identified for 
certain coordination modes. This greater number of conformations suggests that these ligands 
do not restrict the flexibility of Aβ to the same extent as the first four ligands. It is also notable 
that the number of conformations for a given coordination mode are similar (ratios 0.76-1.27, 
Table 1), but vary dramatically across the ligand series (ratios 0.57-2.67). This suggests that 
the nature of the ligand affects the flexibility of Aβ more than the coordination mode. 
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As we have shown previously,31 PM7/COSMO optimization of each conformation is able to 
provide both accurate geometries and relative energies of these systems. We therefore 
performed this step for all conformations identified above, a total of over 52,000 
conformations. The resulting relative energies were collated and used in Boltzmann weighting 
calculations to determine the binding mode(s) and conformation(s) that contribute significantly 
to the overall ensemble at 310 K, the results of which are reported inTable 2. While low energy 
conformations are the main focus of this work, we note that the range of relative energy of 
conformations found in this process is large: the maximum PM7 energy is (1): 583, (2): 403, 
(3): 233, (4): 372, (5): 657, (6): 726 kJmol-1. That such high-energy conformations survive 
LFMM followed by PM7 optimization is slightly surprising, but gives us reassurance that the 
conformational freedom of the peptide has been sampled. We also note that PM7 optimization 
resulted in between 10 and 20 (1 to 2%) of conformations reported in Table 1 no longer being 
unique, a small value that attests to the quality of the geometries that result from LFMM.
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On the basis of these results, we predict that the binding of PtII to histidine residues is strongly 
dependent on the identity of the ligand, though these systems exhibit some preference for PtII-
binding via Nİ rather than Nį in His residues.  This appears to be an inherent property of the 
histidyl residue: calculations on a series of model PtII(Ligand)(Cl)His complexes using PM7 
gives preference for Nİ binding in His residues, except in the case of ligands 4 and 6, where 
His binding via Nį is strongly favoured (see Table 3). However, the relative stability of Nİ vs. 
Nį binding in these model systems is not always reflected in the full peptide systems (see Table 
2, with particular emphasis on ligand 6) i.e. this preference can be overcome by stabilising 
other binding modes with π-π interactions and/or low strain peptide conformations.  
 
In the model systems using asymmetric ligands (5 and 6) the orientation of the ligands appears 
to be important; the coordination of ligand 5 when His coordinates trans- to the 6-membered 
ring is significantly more stable than when His coordinates cis- to the 6-membered ring (see 
Figure 2 for reference). Interestingly, while Nİ binding is favoured by approximately the same 
amount in the first two ligand systems, there is very little energy difference between the Nį/Nİ 
binding for the ligand 3. This may go some way to explaining the mixed Nį/Nİ coordination 
mode seen in the low energy conformations (Table 2). 
Furthermore, the orientation of the ligand remains important in the full peptide systems: in the 
case of ligand 5, the lowest energy conformation where His6 coordinates trans- to the 6-
membered ring rather than the 5-membered ring is located 46 kJ/mol above the most stable 
conformer. Similarly, in the case of ligand 6, the first conformation identified where His6 
coordinates trans- to the 6-membered ring appears 49 kJ/mol above the minimum energy 
conformer.  
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The data in Table 2 also indicate that a very small number of conformations contribute 
significantly to the Boltzmann-weighted ensemble at 310K. For ligands 1, 3 and 4, a single 
conformer dominates the ensembles, whereas for 2, 5 and 6 several conformers are predicted 
to co-exist with significant probability. The alternative low energy conformations of these 
complexes are discussed in more detail below. These results are consistent with our previous 
findings and reinforce the assertion that coordination of these PtII complexes greatly reduces 
conformational freedom of Aβ31. The low energy conformations identified in Table 2 are 
shown in Figure 3. Table 2 also shows there is distinct preference in coordination mode for 
each of the ligands studied; this coordination is summarised in Table 4 below. This is a 
promising result in the case of ligand 2 since the metal binding mode we identify as the most 
favourable (His6 İ – His14 İ) agrees with existing experimental data obtained by εa et al.19 
This also suggests that changing the ligand bound to platinum is able to influence the preferred 
PtII-binding mode and thus, that the binding mode may be controlled through choice and design 
of the ligand. 
 
To investigate these results further, we focus on two structural features: i) PtII coordination and 
ii) peptide backbone geometry in order to assess the range of geometries sampled in the 
conformational searching process, and to identify any features of low energy conformations. 
 
The calculated bond lengths and angles around the central platinum in each ligand system are 
summarised in Table 5. These data show that there is little variation in Pt—NHis bond lengths 
following change in conformation and/or coordinated ligand, but that there is notable variation 
of the Pt-NLig bond distances across the range of ligands. Additionally, these data show that 
there is a systematic difference in length of the Pt-NLig and Pt-NHis bonds – specifically the 
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average Pt-NHis bond distances are slightly shorter than the corresponding Pt-NLig bond 
distances. However, comparison with the geometrical data for the low energy conformations 
(Table 5) clearly shows that these stable structures are not significantly different from the 
average conformation in each case, suggesting that the platinum geometry is not especially 
important in determining complex stability. It is also notable that these Pt—N distances are in 
good agreement with those of Streltsov et al.22 for ligand 2, who reported Pt–N(imidazole) and 
Pt–N(phen) bond distances of 2.03(1) Å and 1.993(5) Å, respectively, as well as confirming 
the square planar coordination of this ligand to amino acids. 
Backbone dihedral angles for all conformations were calculated, allowing Ramachandran plots 
to be constructed. This allows us to identify any secondary structure forming within the usually 
random coil N-terminal region of Aβ. The free Aβ6-14 fragment was modeled using an 
identical protocol, which identified 9962 possible conformations; backbone dihedrals for these 
conformations were calculated and used to produce a Ramachandran map using JMP43 (See 
Figure 4). In agreement with previous findings,46,47,48,49 this fragment of the Aβ peptide is 
highly flexible, illustrated by the wide coverage of the Ramachandran plot. Conformations are 
concentrated around two distinct right-handed helical regions of conformational space, with 
smaller contributions from β-sheet and turn regions. Values of  for the lowest energy 
conformation located are reported in Table 6, and secondary structure assigned by STRIDE50 
in Table 7. Despite occupying the region of  space expected for helices, residues are best 
described as turn/coil due to lack of H-bonding expected in α- and 310-helices, in agreement 
with the findings of Yang and Teplow49. Those authors also identified ‘highly populated turn 
structures, centred at [residues] 6-9’ of the free Aβ peptide, and highlighted the importance of 
such turns for aggregation. 
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Ramachandran plot were then generated for each PtII(ligand) system studied. For example, 
Figure 5 shows that for the favoured His6 İ - His14İ coordination of the platinum complex 
with ligand 2, conformations cover a similar range to that observed for the free peptide, but the 
concentration of residues in the right-handed helical region is reduced, with much greater 
scatter of  in the area expected for helical peptides, including a significant contribution at 
negative /positive . Moreover, the Pt(2) complex exhibits a greater propensity for turn-like 
structures centred around +70/-60°. Analogous plots for each coordination mode with ligand 2 
(see SI) illustrate Ramachandran maps are broadly similar regardless of platinum binding 
mode. As noted above, three complexes exhibit multiple low-energy conformations: backbone 
dihedrals for alternative conformations are reported in ESI (Table S1). In all cases, the second 
lowest energy conformation has similar backbone conformation to the lowest energy one, and 
in Pt(6) especially the third conformation differs only in one angle of one residue (Tyr10). 
Thus, even in cases where multiple conformations are identified the overall flexibility of the 
peptide backbone is still very restricted. 
However, as illustrated in Table 2, many of the generated conformations are of relatively high 
energy, so are of little biological relevance. The peptide geometries within these low energy 
conformations are summarized in Table 6. Analysis of these conformations using STRIDE to 
identify any secondary structure elements was performed and results shown in Table 7. Data 
for the free peptide are in agreement with previous findings49 of a turn in residues 5 – 9, with 
coil-like structure in residues 10-14. In general, a clear picture of disruption of the free 
peptide’s turn between residues 5 and 10 emerges from this analysis. The detailed effect of 
platination on this pattern varies with ligand: in most cases, a mix of turn and coil values are 
found, but the location of the turn residues changes. Pt(3) is probably the closest to the free 
peptide but truncates the observed turn by two residues, whereas Pt(2), Pt(4) and Pt(6) move 
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the turn later in the sequence. Interestingly, STRIDE identifies a short stretch of 310-helix in 
the low energy Pt(1) structure, while Pt(5) is assigned as almost completely turn in nature.  
 
Conformations were also analysed for close contacts between peptide and ligand, defined as 
the distance between C in a residue and a C atom in the centre of the ligand. This revealed 
that Tyr10 in particular forms numerous contacts with ligands, and that such contacts are more 
prevalent in the favoured coordination modes than in alternative forms. Full details of 
intramolecular distances can be found in supporting information: as an example, Figure 6 
compares such contacts between the favoured coordination mode and the next most stable for 
Pt(1) and Pt(2). In both cases, the favoured coordination mode exhibits a distribution skewed 
towards short distances between ligand and Tyr10. The situation is less clear cut for other 
ligands, but in general the favoured coordination mode has on average one of the shortest 
contact distances. We speculate, therefore, that such formation of such contacts are one of the 
main factors in determining how a particular ligand system alters how platinum binds to A. 
 
 
Conclusions 
LFMM is a powerful modelling tool for the study of transition metal complexes and has 
previously found success in predicting their interactions with biomolecules. In this work, we 
apply the LFMM approach to a series of six PtII complexes - as studied by Barnham16,17,45  and 
others19,20,21 - and their interaction with model fragments of the amyloid-β peptide in order to 
determine favourable metal binding modes as well as their influence on peptide secondary 
structure. Conformational space of Aβ was explored using δowεode εD with AεBER 
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molecular mechanics parameters, followed by further optimisation using the semi-empirical 
PM7 method. 
Boltzmann populations for each conformation were calculated at 310K and favourable 
platinum binding modes were identified for each complex studied. The preferred binding mode 
was found to be dependent on the nature of the ligand, with varied Nį or Nİ coordination across 
the N-terminal histidine residues of Aβ. These changes in binding mode suggest that the 
platinum coordination may be controlled via the choice of the ligand. Furthermore, the 
Boltzmann populations for these complexes indicate that a small number of conformations 
contribute significantly to the ensemble at 310K, suggesting that the flexibility of the peptide 
is severely reduced after coordination of these platinum complexes.  
Analysis of the platinum coordination geometry illustrated that the low energy conformations 
were not significantly different from the average across databases, meaning that their stability 
is likely conferred by the peptide conformation rather than the metal geometry, and in particular 
close contacts between residue side chains the planar ligands. It is surprising that such ligands, 
which differ only slightly in their steric and electronic nature, effect such large changes on 
coordination and conformation. The available peptide conformations were plotted as 
Ramachandran maps, allowing for identification of secondary structure elements within the 
peptide. While the N-terminal region of Aβ is known to be disordered, the most stable 
conformation of the free peptide found here was shown to exhibit turn-type secondary structure 
in residues His6-Glu11. Coordination of each platinum-ligand complex disrupts this secondary 
structure differently, including interrupting or translating the existing turn-type structure as 
well as formation of a short 3,10-helix. Restricting the conformational freedom and disrupting 
the secondary structure of Aβ may have consequences for the effect of these complexes on 
limiting aggregation, for instance by hindering the formation of β-sheet structures known to be 
important in plaques.  
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In future, there are several research avenues to be pursued. Firstly, the peptide system will be 
extended to more biologically relevant 1-16, 1-28 subunit and the full peptide. In addition, the 
modelling approaches outlined here may be applied to the study of cyclo-metalated ligands 
such as those of Collin et al20. Alternatively, the LFMM procedure may be applied to other 
transition-metal based therapeutics (e.g. ruthenium32 and mixed-metal complexes33) or the 
physiologically important copper, iron and zinc ions34, though these approaches may require 
the development of new LFMM parameters. 
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Table 1: Number of conformers found for each platinum coordination mode using LowMode 
MD for the six ligands studied. 
Coordination 
mode 
1 2 3 4 5 6  Ratioa  
His6 į – His13 į 893 425 477 970 2531 1595  1.00 
His6 į – His13 İ 426 495 1114 423 1640 3254  1.07 
His6 İ - His13 į 484 468 469 680 1736 1707  0.80 
His6 İ - His13 İ 995 405 434 670 1709 1556  0.84 
His6 į - His14 į 574 411 1407 508 1204 4627  1.27 
His6 į - His14 İ 1570 454 513 626 3146 1152  1.08 
His6 İ - His14 į 429 618 404 403 1430 2118  0.78 
His6 İ - His14 İ 1135 450 768 298 1226 1350  0.76 
        
 
Ratiob 1.00 0.57 0.86 0.70 2.67 2.25   
a
 Ratio of the total number of conformations of a coordination mode, relative to His6 į - His13 į; b Ratio 
of the total number of conformations of a ligand, relative to 1. 
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Table 2: Relative energy and Boltzmann factors at 310K for low energy conformations. 
Ligand Coordination Rel. E /  kJ mol-1 
Boltzmann 
fraction 
1 His6 İ – His13 İ 0.00 0.79 
 His6 İ – His13 İ 6.27 0.07 
 His6 İ – His13 İ 7.07 0.05 
 His6 İ – His13 İ 7.51 0.04 
    
2 His6 İ – His14 İ 0.00 0.38 
 His6 İ – His14 İ 0.77 0.28 
 His6 İ – His14 İ 1.96 0.18 
 His6 İ – His14 İ 4.14 0.08 
 His6 İ – His14 İ 4.38 0.07 
    
3 His6 į – His13 İ 0.00 0.67 
 His6 į – His13 İ 5.80 0.07 
 His6 į – His13 İ 6.30 0.06 
 His6 İ – His13 İ 6.45 0.05 
 His6 İ – His14 İ 7.54 0.04 
    
4 His6 į – His14 į 0.00 0.99 
 His6 İ – His13 į 12.69 0.01 
 His6 İ – His13 į 13.22 0.01 
    
5 a
 His6 į – His14 İ  0.00 0.39 
 
a
 His6 į – His14 İ 0.31 0.34 
 
a
 His6 į – His14 İ 3.00 0.12 
 
a
 His6 į – His14 İ 5.42 0.05 
    
6 a
 His6 İ – His14 İ 0.00 0.47 
 
a
 His6 İ – His14 İ 1.79 0.23 
 
a
 His6 İ – His14 İ 2.28 0.19 
 
a
 His6 į – His14 į 3.74 0.11 
a
 trans to 5-membered ring 
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Table 3: PM7 and DFT (BHandH/6-31G*-SDD) relative energies of different His binding 
modes in PtII(ligand)(Cl)His model systems. 
Ligand Nį / Nİ Binding PM7 Rel. E / 
kJmol-1 
DFT Rel. E / 
kJmol-1 
1 į 6.79 17.46 
 İ 0.00 0.00 
    
2 į 7.84 9.01 
 İ 0.00 0.00 
    
3 į 1.09 10.68 
 İ 0.00 0.00 
    
4 į 0.00 0.00 
 İ 19.50 21.84 
    
5 į1 a 4.08 2.75 
 į2 b 1.77 6.88 
 1 a 4.26 1.85 
 2 b 0.00 0.00 
    
6 į1 a 0.00 0.00 
 į2 b 25.59 12.46 
 1 a 18.57 28.36 
 2 b 17.22 24.20 
a
 trans to 5-membered ring; b trans to 6-membered ring 
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Table 4: Favoured PtII-coordination mode for each ligand system.  
Ligand Coordination mode 
1 His6 İ – His13 İ 
2 His6 İ – His14 İ 
3 His6 į – His13 İ 
4 His6 į – His14 į 
5 a His6 į – His14 İ  
6 a His6 İ – His14 İ 
a
 His6 coordinated trans to 5-membered ring 
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Table 5: Selected geometrical parameters over all conformations for each ligand (Å and °). 
First line: average and standard deviation; second line: value from lowest energy conformer 
Ligand Pt-NLig  Pt-NHis His-Pt-His 
1 1.982 ± 0.005 1.966 ± 0.004 84.5 ± 1.75 
 1.986 ± 0.000 1.963 ± 0.003 88.5 
2 1.993 ± 0.059 1.967 ± 0.050 85.7 ± 3.65 
 1.991 ± 0.003 1.960 ± 0.001 85.2 
3 1.986 ± 0.005 1.966 ± 0.006 85.5 ± 2.10 
 1.984 ± 0.000 1.960 ± 0.001 85.1 
4 1.986 ± 0.031 1.967 ± 0.018 86.2 ± 2.15 
 1.983 ± 0.001 1.964 ± 0.003 87.4 
5 1.976 ± 0.037 1.968 ± 0.057 87.0 ± 2.65 
 1.975 ± 0.013 1.963 ± 0.006 88.1 
6 1.984 ± 0.040 1.965 ± 0.037 86.3 ± 2.38 
 1.983 ± 0.014 1.961 ± 0.002 82.5 
 
Table 6: Dihedral angles of the lowest energy conformations for free Aβ in addition to each 
Pt(ligand) complex studied. 
 Ligand 
  Free Aβ 1 2 3 4 5 6 
φ His6 -77.63 -94.8 -130.9 -81.2 -115.9 -125.7 -88.7 
ΨHis6 -21.71 -49.4 -91.6 172.4 -64.0 -52.2 -27.5 
φ Asp7 -131.10 -143.0 -67.1 -101.0 -130.5 -52.1 -149.6 
ΨAsp7 -50.71 -17.3 -46.5 7.2 -34.6 177.6 -67.1 
φ Ser8 -162.66 76.1 -152.9 -149.0 -154.5 -149.1 -99.5 
ΨSer8 6.28 -5.8 174.9 162.7 -67.2 -46.3 -76.3 
φ Gly9 82.45 -110.3 -87.6 -80.3 101.2 -81.5 -112.6 
ΨGly9 -42.98 -68.8 159.7 81.2 11.2 4.8 -95.0 
25 
 
φ Tyr10 -86.25 -66.3 173.9 -131.7 -59.1 114.8 -126.4 
ΨTyr10 -9.01 -12.5 38.9 -21.1 -25.4 32.6 73.1 
φ Glu11 70.26 -28.0 -157.3 -113.3 -99.1 77.7 -109.0 
ΨGlu11 11.08 -43.4 -108.8 -124.6 -10.4 55.9 -81.5 
φ Val12 -130.56 -55.5 -128.0 -101.4 74.0 -128.2 168.3 
ΨVal12 66.87 -5.8 -22.5 -27.6 37.3 -33.6 -30.7 
φ His13 -122.68 -67.6 -102.8 -109.8 -132.7 -116.0 -61.4 
ΨHis13 -32.98 -19.6 -47.6 -34.6 -53.2 -10.1 -15.4 
φ His14 56.00 -111.1 -106.3 76.4 -96.1 103.1 -51.3 
ΨHis14 17.84 -45.7 -0.2 -50.1 19.7 33.9 -30.7 
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Table 7: Secondary structure analysis of the low energy conformations of free Aβ and each 
Pt(ligand) system studied using STRIDE50. 
Residue Free Aβ Pt(1) Pt(2) Pt(3) Pt(4) Pt(5) Pt(6) 
His6 Turn Coil Coil Turn Coil Coil Coil 
Asp7 Turn Turn Coil Turn Coil Turn Coil 
Ser8 Turn Turn Turn Turn Coil Turn Coil 
Gly9 Turn Turn Turn Turn Turn Turn Coil 
Tyr10 Turn Turn Turn Coil Turn Turn Turn 
Glu11 Turn 3,10 Turn Coil Turn Turn Turn 
Val12 Coil 3,10 Turn Coil Turn Turn Turn 
His13 Coil 3,10 Turn Coil Coil Turn Turn 
His14 Coil Coil Coil Coil Coil Turn Coil 
 
  
27 
 
 
 
Figure 1. Schematic of PtII(ligand) binding to residues 6-14 of Aβ peptide. 
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Figure 2: Schematic of ligand systems studied. (left-right: bipyridyl (1), phenanthroline (2), 
diphenylphenanthroline (3), dppz (4), 8-(1H-benzimidazol-2-yl)quinolone17,44 (5) and 2-
pyridyl-benzimidazole45 (6). 
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Figure 3: Top row: Low energy conformations of Pt(1) (left) and Pt(2) (right). Middle row: Low energy conformations of Pt(3) (left) and Pt(4) 
(right). Bottom row: Low energy conformations of Pt(5) (left) and Pt(6) (right). 
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Figure 4: Ramachandran map of the generated conformations of the free aβ6-14 fragment, plotted using JMP43. 
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Figure 5: Comparison of Ramachandran maps for the generated conformations of the low energy binding modes for the six different PtII-Aβ 
systems studied.
33 
 
  
a b 
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Figure 6: Ligand-Tyr10 distances in a) Pt(1) His6 İ - His13 İ, b) Pt(1) His6 į - His13 İ, 
c) Pt(2) His6 İ - His14 İ and d) His6 į – His13 į. 
 
